MRNA
Moderna, Inc.
NASDAQ · Healthcare · Biotechnology · US
$145.08
−2.55%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 29.76x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.57x
- Price / sales
- 26.00x
- Price / cash flow
- -55.06x
Enterprise value
- Enterprise value
- $54.1B
- EV / sales
- 24.27x
- EV / EBITDA
- -19.11x
- EV / EBIT
- -16.29x
- Market cap
- $57.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026